Travere Therapeutics, Inc.
US ˙ NasdaqGM ˙ US89422G1076

SecurityTVTX / Travere Therapeutics, Inc.
InstitutionAlliancebernstein L.p.
Latest Disclosed Ownership143,817 shares
Latest Disclosed Value $ 5,495,248
Alliancebernstein L.p. reports 14.99% increase in ownership of TVTX / Travere Therapeutics, Inc.

On May 15, 2026 - Alliancebernstein L.p. filed a 13F-HR form disclosing ownership of 143,817 shares of Travere Therapeutics, Inc. (US:TVTX) valued at $4,272,803 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 125,069 shares of Travere Therapeutics, Inc.. This represents a change in shares of 14.99% during the quarter. The current value of the position is $6,500,528 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 143,817 18,748 14.99 5,495 15.01 0.0018
2026-02-17 2025-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 125,069 -197,046 -61.17 4,779 -37.93 0.0015
2025-11-14 2025-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 322,115 -21,746 -6.32 7,699 51.27 0.0024
2025-08-14 2025-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 343,861 -74,736 -17.85 5,089 -32.16 0.0017
2025-05-15 2025-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 418,597 347,967 492.66 7,501 509.84 0.0027
2025-02-12 2024-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 70,630 0 0.00 1,230 24.49 0.0004
2024-11-14 2024-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 70,630 0 0.00 988 70.34 0.0003
2024-08-14 2024-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 70,630 10 0.01 581 6.62 0.0002
2024-05-14 2024-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 70,620 0 0.00 544 -14.20 0.0002
2024-02-14 2023-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 70,620 0 0.00 635 0.48 0.0002
2023-11-14 2023-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 70,620 0 0.00 631 -41.79 0.0003
2023-08-15 2023-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 70,620 11,300 19.05 1,085 -18.74 0.0004
2023-05-15 2023-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 59,320 0 0.00 1,334 6.98 0.0006
2023-02-15 2022-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 59,320 -13 -0.02 1,248 -14.71 0.0006
2022-11-15 2022-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 59,333 0 0.00 1,462 1.67 0.0007
2022-08-15 2022-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 59,333 13 0.02 1,438 -5.95 0.0007
2022-05-13 2022-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 59,320 100 0.17 1,529 -16.81 0.0006
2022-02-14 2021-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 59,220 0 0.00 1,838 27.99 0.0006
2021-11-10 2021-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 59,220 -4,300 -6.77 1,436 54.91 0.0006
2021-07-30 2021-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 63,520 -77,160 -54.85 927 -73.61 0.0004
2021-05-06 2021-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 140,680 77,160 121.47 3,513 102.95 0.0015
2021-02-08 2020-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 63,520 7,800 14.00 1,731 68.22 0.0008
2020-11-12 2020-09-30 13F RETROPHIN COM 761299106 55,720 6,600 13.44 1,029 2.59 0.0006
2020-08-13 2020-06-30 13F RETROPHIN COM 761299106 49,120 2,700 5.82 1,003 48.15 0.0006
2020-05-14 2020-03-31 13F RETROPHIN COM 761299106 46,420 0 0.00 677 2.73 0.0005
2020-02-18 2019-12-31 13F RETROPHIN COM 761299106 46,420 0 0.00 659 22.49 0.0004
2019-11-14 2019-09-30 13F RETROPHIN COM 761299106 46,420 -59,190 -56.05 538 -74.65 0.0003
2019-08-14 2019-06-30 13F RETROPHIN COM 761299106 105,610 0 0.00 2,122 -11.21 0.0013
2019-05-14 2019-03-31 13F RETROPHIN COM 761299106 105,610 -3,000 -2.76 2,390 -2.77 0.0016
2019-02-13 2018-12-31 13F RETROPHIN COM 761299106 108,610 0 0.00 2,458 -21.22 0.0018
2018-11-08 2018-09-30 13F RETROPHIN COM 761299106 108,610 0 0.00 3,120 5.37 0.0020
2018-08-13 2018-06-30 13F RETROPHIN COM 761299106 108,610 -152,860 -58.46 2,961 -49.35 0.0021
2018-05-14 2018-03-31 13F RETROPHIN COM 761299106 261,470 61,000 30.43 5,846 38.40 0.0042
2018-02-13 2017-12-31 13F RETROPHIN COM 761299106 200,470 25,000 14.25 4,224 -3.27 0.0030
2017-11-13 2017-09-30 13F RETROPHIN COM 761299106 175,470 77,450 79.01 4,367 129.72 0.0033
2017-08-10 2017-06-30 13F RETROPHIN COM 761299106 98,020 50,000 104.12 1,901 114.56 0.0015
2017-05-11 2017-03-31 13F RETROPHIN COM 761299106 48,020 -82 -0.17 886 -2.74 0.0007
2017-02-13 2016-12-31 13F RETROPHIN COM 761299106 48,102 82 0.17 911 -15.26 0.0008
2016-11-10 2016-09-30 13F RETROPHIN COM 761299106 48,020 0 0.00 1,075 25.73 0.0009
2016-08-11 2016-06-30 13F RETROPHIN COM 761299106 48,020 -3,610 -6.99 855 21.28 0.0007
2016-05-13 2016-03-31 13F RETROPHIN COM 761299106 51,630 0 0.00 705 -29.22 0.0006
2016-02-16 2015-12-31 13F/A-1 RETROPHIN COM 761299106 51,630 0 0.00 996 -4.78 0.0008
2016-02-12 2015-12-31 13F RETROPHIN COM 761299106 51,630 1,046
2015-11-13 2015-09-30 13F RETROPHIN COM 761299106 51,630 820 1.61 1,046 -37.89 0.0009
2015-08-14 2015-06-30 13F RETROPHIN COM 761299106 50,810 36,600 257.57 1,684 395.29 0.0014
2015-05-13 2015-03-31 13F RETROPHIN COM 761299106 14,210 4,600 47.87 340 188.14 0.0003
2015-02-13 2014-12-31 13F RETROPHIN COM 761299106 9,610 -4,600 -32.37 118 -7.81 0.0001
2014-11-13 2014-09-30 13F RETROPHIN COM 761299106 14,210 0 0.00 128 -23.35 0.0001
2014-08-13 2014-06-30 13F RETROPHIN COM 761299106 14,210 12,400 685.08 167 339.47 0.0001
2014-05-13 2014-03-31 13F RETROPHIN COM 761299106 1,810 1,810 38 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.